Jamieson Wellness Inc. (OTCMKTS:JWLLF) Short Interest Up 419.6% in July

Jamieson Wellness Inc. (OTCMKTS:JWLLF) was the recipient of a significant growth in short interest in July. As of July 31st, there was short interest totaling 404,709 shares, a growth of 419.6% from the July 15th total of 77,891 shares. Based on an average daily volume of 12,221 shares, the days-to-cover ratio is presently 33.1 days.

Analyst Ratings Changes

JWLLF has been the topic of a number of research analyst reports. Citigroup cut shares of Jamieson Wellness to a “hold” rating in a report on Friday. Canadian Imperial Bank of Commerce restated an “outperform” rating on shares of Jamieson Wellness in a report on Friday, May 8th. Royal Bank Of Canada downgraded shares of Jamieson Wellness from an “outperform” rating to a “sector perform” rating in a research report on Monday. Finally, National Bank Financial reiterated an “outperform” rating on shares of Jamieson Wellness in a research note on Friday, June 26th. Two equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, Jamieson Wellness has a consensus rating of “Moderate Buy”.

Jamieson Wellness Price Performance

Jamieson Wellness stock opened at $32.76 on Wednesday. Jamieson Wellness has a fifty-two week low of $23.88 and a fifty-two week high of $32.76. The stock has a 50-day simple moving average of $28.46 and a 200-day simple moving average of $26.51.

Jamieson Wellness Company Profile

Jamieson Wellness is a leading Canadian manufacturer and distributor of nutraceutical products, including vitamins, minerals, herbal remedies and dietary supplements. Founded in 1922, the company has grown to offer a diverse portfolio of formulations designed to support general health, immune function, digestion and other specialized wellness needs. Its flagship Jamieson brand is complemented by sub-brands such as bkind, reflecting a commitment to innovation and consumer choice across a range of tablet, capsule and gummy formats.

The company serves both domestic and international markets through a multi-channel approach that includes major mass and drug retailers, specialty stores and direct-to-consumer e-commerce platforms.